Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

NCT00471484 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

BIOLOGICAL: recombinant interferon alfa-2b
DRUG: doxorubicin hydrochloride
DRUG: fluorouracil
DRUG: oxaliplatin
OTHER: diagnostic laboratory biomarker analysis
OTHER: immunoenzyme technique
OTHER: immunohistochemistry staining method
PROCEDURE: adjuvant therapy
PROCEDURE: biopsy
PROCEDURE: neoadjuvant therapy
PROCEDURE: therapeutic conventional surgery

Sponsor

National Cancer Centre, Singapore